LAKE OSWEGO, Ore., April 10, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will provide a presentation entitled “Implementing Phase III Vaccine Trials” at the World Vaccine Trials Congress. The presentation will take place on Wednesday, April 11, 2012 at 3:30 PM EDT at the Gaylord National Convention Center in Washington D.C.
